Active Filters

  • (-) Keywords = SPECT/CT
Search Results 1 - 5 of 5
  • RSS Feed
Select Page
Radioiodinated folic acid conjugates: evaluation of a valuable concept to improve tumor-to-background contrast
Reber, J., Struthers, H., Betzel, T., Hohn, A., Schibli, R., & Müller, C. (2012). Radioiodinated folic acid conjugates: evaluation of a valuable concept to improve tumor-to-background contrast. Molecular Pharmaceutics, 9(5), 1213-1221. https://doi.org/10.1021/mp200511t
A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours
García-Garayoa, E., Bläuenstein, P., Blanc, A., Maes, V., Tourwé, D., & Schubiger, P. A. (2009). A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours. European Journal of Nuclear Medicine and Molecular Imaging, 36(1), 37-47. https://doi.org/10.1007/s00259-008-0894-y
Evaluation of a novel radiofolate in tumour-bearing mice: promising prospects for folate-based radionuclide therapy
Müller, C., Mindt, T. L., de Jong, M., & Schibli, R. (2009). Evaluation of a novel radiofolate in tumour-bearing mice: promising prospects for folate-based radionuclide therapy. European Journal of Nuclear Medicine and Molecular Imaging, 36(6), 938-946. https://doi.org/10.1007/s00259-008-1058-9
Pemetrexed improves tumor selectivity of <sup>111</sup>In-DTPA-folate in mice with folate receptor-positive ovarian cancer
Müller, C., Schibli, R., Krenning, E. P., & de Jong, M. (2008). Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer. Journal of Nuclear Medicine, 49(4), 623-629. https://doi.org/10.2967/jnumed.107.047704
SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel <sup>99m</sup>Tc-radiofolate
Müller, C., Forrer, F., Schibli, R., Krenning, E. P., & de Jong, M. (2008). SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate. Journal of Nuclear Medicine, 49(2), 310-317. https://doi.org/10.2967/jnumed.107.045856